Aéroports de Paris SA - Information regarding the voting rights and shares as of 30 November 2020
3 December 2020
Aéroports de Paris SA
Information regarding the voting rights and shares
as of 30 November 2020
Statement according to Article L. 233-8-II of the French Commercial Code and 223-16 of the General Regulations of the “Autorité des Marchés Financiers”
ISIN: FR0010340141
Ticker: ADP
Listing place: Euronext Paris
Market: Euronext Paris - Compartment A – SRD
| Date | Total number of shares | Total number of gross voting rights | Total number of net voting rights1 |
| 30/11/2020 | 98,960,602 | 171,789,657 | 171,773,347 |
1Gross voting rights less shares without voting rights
Investor Relations: Audrey Arnoux, Head of Investor Relations +336 61 27 07 39-invest@adp.fr
Press contact: Lola Bourget, Head of Medias and Reputation Department +33 1 74 25 23 23
Groupe ADP develops and manages airports, including Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. In 2019, the group handled through its brand Paris Aéroport more than 108 million passengers and 2.2 million metric tons of freight and mail at Paris-Charles de Gaulle and Paris-Orly, and more than 110 million passengers in airports abroad. Boasting an exceptional geographic location and a major catchment area, the Group is pursuing its strategy of adapting and modernizing its terminal facilities and upgrading quality of services; the group also intends to develop its retail and real estate businesses. In 2019, group revenue stood at €4,700 million and net income at €588 million.
Registered office: 1 rue de France – 93290 Tremblay en France, France. A public limited company (Société Anonyme) with share capital of €296,881,806. Registered in the Bobigny Trade and Company Register under no. 552 016 628.
groupeadp.fr
Attachment
© 2020 GlobeNewswire, Inc. All Rights Reserved.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
